ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

TITLE:

THE PREVALENCE OF DIABETIC RETINOPATHY AND VISUAL IMPAIRMENT IN PATIENTS WITH DIABETES MELLITUS IN AL QASSIM REGION, SAUDI ARABIA. A DESCRIPTIVE RETROSPECTIVE STUDY

AUTHORS:

1Rasha Mohammed Almotairi, 2Mohammed Majed Alotaibi, 3Jehad Ahmed Alshaban, 4Musa Johaiman Alrashedi, 5Mariya Abdullah Alhashim, 6Faisal Mohammed Alarjan, 7Arwa Mohammed ALthubaity, 8Rawabi Aied Algethami, 9Razan Ghazi Almehmadi, 10Nasir A Ali, 11Dr. Abbas Mohammed, 12Dr. Naeem Munir

ABSTRACT:

Diabetic retinopathy (DR) is one of the serious potential complications. It occurs in approximately 77% of the type 2 diabetics within 10 years of the diabetes onset, and almost in all type 1 diabetics. This descriptive retrospective study was conducted by using simple random sample, where data was collected by the research team from patients records by using well designed questionnaire, so 240 patients medical records from King saud hospital in Onaizah at Al qassim region were selected randomly and critically reviewed to measure the prevalence of diabetic retinopathy and visual impairment in patients with diabetes mellitus. Data was collected by the research team from patients records by using well designed questionnaire. Collected data was analyzed using Statistical Package for Social Sciences (SPSS. Ver. 20) where descriptive and analytical statistics were conducted where applicable. This study indicated that the prevalence of diabetic retinopathy was 66% while 82% of patients had visual impairment. It also stated that there was statistically significant relationship between; patients ages in year, period of diabetes since diagnosed in years and the visual impairment and between; patients ages in year, and presence of Diabetic retinopathy, p value was less than 0.05 Keywords: Diabetic retinopathy, visual impairment, diabetes mellitus, Al qassim , Saudi Arabia

FULL TEXT

Top
  • Follows us on
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.